DE2620280A1 - Steroidderivate und verfahren zu ihrer herstellung - Google Patents

Steroidderivate und verfahren zu ihrer herstellung

Info

Publication number
DE2620280A1
DE2620280A1 DE19762620280 DE2620280A DE2620280A1 DE 2620280 A1 DE2620280 A1 DE 2620280A1 DE 19762620280 DE19762620280 DE 19762620280 DE 2620280 A DE2620280 A DE 2620280A DE 2620280 A1 DE2620280 A1 DE 2620280A1
Authority
DE
Germany
Prior art keywords
hydroxy
mixture
dienolide
compound
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762620280
Other languages
German (de)
English (en)
Inventor
Gunther Kruger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steele Chemicals Co Ltd
Original Assignee
Steele Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steele Chemicals Co Ltd filed Critical Steele Chemicals Co Ltd
Publication of DE2620280A1 publication Critical patent/DE2620280A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DE19762620280 1975-05-07 1976-05-07 Steroidderivate und verfahren zu ihrer herstellung Withdrawn DE2620280A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB19144/75A GB1553222A (en) 1975-05-07 1975-05-07 14 - hydroxy 3- eoxycardenolides

Publications (1)

Publication Number Publication Date
DE2620280A1 true DE2620280A1 (de) 1976-12-02

Family

ID=10124489

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762620280 Withdrawn DE2620280A1 (de) 1975-05-07 1976-05-07 Steroidderivate und verfahren zu ihrer herstellung

Country Status (9)

Country Link
US (1) US4102884A (enExample)
JP (1) JPS51136664A (enExample)
CA (1) CA1090330A (enExample)
DE (1) DE2620280A1 (enExample)
DK (1) DK203576A (enExample)
FR (1) FR2310132A1 (enExample)
GB (1) GB1553222A (enExample)
NO (1) NO761569L (enExample)
SE (1) SE7605069L (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234577A (en) * 1979-03-19 1980-11-18 Z-L Limited Partnership Ergostadientriols, compositions containing same, and methods of preparing and using same
US4259240A (en) * 1979-09-28 1981-03-31 Advance Biofactures Corporation Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom
CN1047598C (zh) * 1993-07-06 1999-12-22 昆明医学院 达玛烷型皂甙人参低元醇衍生物及制备方法
GB0713463D0 (en) 2007-07-11 2007-08-22 Btg Int Ltd Modulators of hypoxia inducible factor-1 and related uses
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
CN104628807B (zh) * 2015-02-10 2016-09-14 中国科学院上海有机化学研究所 16-烯-20-羟基甾体化合物的合成方法
US20240417425A1 (en) * 2021-12-17 2024-12-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cardiac steroid derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3087944A (en) * 1959-02-03 1963-04-30 Advance Growth Capital Corp 19-methyl-19-acyloxy strophanthidin derivatives
GB1426170A (en) * 1972-12-27 1976-02-25 Radiochemical Centre Ltd Selenium-75 derivatives of steroids
US3981982A (en) * 1974-09-11 1976-09-21 Abbott Laboratories Radioimmunoassay for determining the digoxin content of a sample

Also Published As

Publication number Publication date
US4102884A (en) 1978-07-25
FR2310132B1 (enExample) 1981-02-27
SE7605069L (sv) 1976-11-08
CA1090330A (en) 1980-11-25
GB1553222A (en) 1979-09-26
JPS51136664A (en) 1976-11-26
NO761569L (enExample) 1976-11-09
DK203576A (da) 1976-11-08
FR2310132A1 (fr) 1976-12-03

Similar Documents

Publication Publication Date Title
DE68927861T2 (de) 11 beta-substituierte progesteron-analoge
EP0254670B1 (de) 11beta-(4-Isopropenylphenyl)-estra-4,9-diene, deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0192598B1 (de) 11 Beta-N,N-Dimethylaminophenyl-Estradiene, deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0283428B1 (de) 19,11beta-Überbrückte Steroide, deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0360369B1 (de) 11Beta-phenyl-14betaH-steroide
DE2620280A1 (de) Steroidderivate und verfahren zu ihrer herstellung
DE68922660T2 (de) 19-Substituierte Progesterone als 19-Hydroxylase-Inhibitoren.
DE1593616A1 (de) Verfahren zur Herstellung von Steroidverbindungen
DE1568308B2 (de) Verfahren zur herstellung von delta hoch 4,9,11-trienen der 19-nor- androstanreihe, 17-oxygenierte 3-oxo- 7 alpha-methyl-delta hoch 4,9,11-19 nor- androstatriene und diese enthaltende pharmazeutische praeparate sowie 3-oxo-7 alpha -methyl-delta hoch 5 (10), 9 (11) -19-nor- androstadiene
DE2309328A1 (de) 3-keto-7(alpha,beta)-nied.-alkyldelta hoch 5-steroide und verfahren zu ihrer herstellung
DE1793618C3 (de) 07.03.63 USA 263441 Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden der Androstanreihe
DE3717169A1 (de) 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE1593052C3 (de) Verfahren zur Herstellung von 16-Methylen-19-norprogesteron-derivaten
CH498818A (de) Verfahren zur Herstellung von neuen 17a-Alka-1',3'-diinyl-17B-hydroxy-steroiden
DE1793608C (de) 17alpha-Alkyl-, -Alkenyl- oder -Alkinyl-13beta-alkylgon-4- oder -5(10)-en-17betaol-3-one. Ausscheidung aus: 1468604
DE1793608B1 (de) 17alpha-Alkyl-,-Alkenyl- oder -Alkinyl-13ss-alkylgon-4-oder-5(10)-en-17ss-ol-3-one
DE2136635A1 (de) Verfahren zur Herstellung von 14beta Hydroxy Delta hoch 16 und 7 alpha Hydroxy Delta hoch 4 steroiden
AT274257B (de) Verfahren zur Herstellung von 17-oxygenierten 3-Oxo-Δ<4,9,11>-trienen der 19-Nor-androstanreihe
DE1493108C (de) Steroidverbindungen
DE2052166A1 (de) Verfahren zur Herstellung von 14 beta, 18 (Epoxyathanoimino) steroiden
DE1813083B2 (de) 11 beta-Methyl-19-norpregn-4-en 3,20-dione, Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel
AT266342B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
DE1793749C3 (de) Verfahren zur Herstellung von 1,4-Diensteroiden
DE2445161A1 (de) D-homo-20-ketopregnane ii
DE2160522A1 (de) Verfahren zur Herstellung von 14 beta, 18- und 5 beta, 19-(Epoxyäthanoimino)steroiden

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee